Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

8 Sep 2023

Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder

A new study by leading academics in the psychedelics space finds that psilocybin combined with therapy could be more cost-effective at treating major depression disorders than currently used methods.

10 Jul 2023

World-renowned researcher receives top award for contributions to clinical psychopharmacology

Dennis Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System, has received the prestigious Donald Klein Lifetime Achievement Award from the American Society for Clinical Psychopharmacology (ASCP).

26 Jun 2023

Xylazine can exacerbate the life-threatening effects of opioids, rat study shows

A new study in rats suggests that xylazine, the active ingredient in a non-opioid veterinary tranquilizer not approved for human use, can worsen the life-threatening effects of opioids.

21 Jun 2023

Truly random drug testing: ADHD patients face uneven urine screens and, sometimes, stigma

Some adults who take prescription medication for attention-deficit/hyperactivity disorder are required to have their urine tested for drugs several times a year. Others never are tested.

28 Mar 2023

Speech pattern analysis can help diagnose, manage psychiatric disorders

Objective measurement of psychiatric disorders has long proved challenging. Yet, there is ample evidence that analysis of speech patterns can accurately diagnose depression and psychosis, measure their severity, and predict their onset, according to a literature review featured in the January/February issue of the Harvard Review of Psychiatry.

9 Jan 2023

Expert panel recommends revisions to gender-affirming care guidelines

Transgender and gender-diverse (TGD) people often seek social, medical, and surgical gender-affirming care from a variety of healthcare professionals.

19 Dec 2022

Johns Hopkins researchers characterize a broad range of psychedelic occasioned belief changes

Johns Hopkins Medicine researchers continue their exploration into psychedelics and how these drugs may produce a wide range of profound changes in perception, cognition and mood.

9 Dec 2022

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

With rising prevalence of depression in adolescents, screening requirements are increasingly falling on pediatric primary care providers, who are encountering more at-risk patients.

15 Sep 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

High-dose supplementation of Vitamin B6 decreases anxiety

Researchers reported that vitamin B6 supplementation reduced anxiety.

25 Jul 2022

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

Taking high-dose Vitamin B6 tablets has been shown to reduce feelings of anxiety and depression by new research.

19 Jul 2022

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

Two drugs, eszopiclone and lemborexant - both not currently licenced for the treatment of insomnia in the UK - were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.

19 Jul 2022

Could Vitamin B6 Reduce Anxiety and Depression?

In this interview, we speak to Dr. David Field about his latest research into anxiety and depression and whether vitamin B6 supplements could help to reduce it.

19 Jul 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a new study from Massachusetts General Hospital finds that treating psychiatric disorders with psychotropic medications in children and adolescents does not increase the risk of developing substance use, misuse, or substance use disorder (SUD).

19 May 2022

Neuroimaging advances show promise in helping transcranial electrical stimulation to effectively treat visual hallucinations

A literature review in Harvard Review of Psychiatry indicates that, while transcranial electrical stimulation (tES) has rarely been used in treating visual hallucinations (VH) among patients with psychiatric disorders, recent advances in neuroimaging technology show promise in helping tES to more effectively treat VH in psychiatric disorders where VH are a core symptom.

13 May 2022

Psychopharmacology News and Research

Further Reading

Research review focuses on the use of psilocybin for treatment of depression

Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder

World-renowned researcher receives top award for contributions to clinical psychopharmacology

Xylazine can exacerbate the life-threatening effects of opioids, rat study shows

Truly random drug testing: ADHD patients face uneven urine screens and, sometimes, stigma

Speech pattern analysis can help diagnose, manage psychiatric disorders

Expert panel recommends revisions to gender-affirming care guidelines

Johns Hopkins researchers characterize a broad range of psychedelic occasioned belief changes

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

High-dose supplementation of Vitamin B6 decreases anxiety

High-dose Vitamin B6 tablets could reduce feelings of anxiety and depression

New Oxford study examines the effectiveness of pharmacological treatments for insomnia

Could Vitamin B6 Reduce Anxiety and Depression?

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

Neuroimaging advances show promise in helping transcranial electrical stimulation to effectively treat visual hallucinations

Two doses of psilocybin may ease depression symptoms for up to 12 months

One in five young adults with substance use disorder may have undiagnosed autistic traits

Study offers new evidence on how childhood immunometabolic risk factors may lead to depression, psychosis

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News